Pathology

Article	Citations
Programmed death ligand-1 (PD-L1) as a predictive marker for immunotherapy in solid tumours: a guide to immunohistochemistry implementation and interpretation	152
SARS-CoV-2 in children: spectrum of disease, transmission and immunopathological underpinnings	74
The 2019 World Health Organization Classification of appendiceal, colorectal and anal canal tumours: an update and critical assessment	64
Laboratory biosafety measures involving SARS-CoV-2 and the classification as a Risk Group 3 biological agent	51
Clear cell papillary renal cell carcinoma: an update after 15 years	38
Chromophobe renal cell carcinoma: current and controversial issues	36
Circulating plasma miR-155 is a potential biomarker for the detection of SARS-CoV-2 infection	34
Clinical and molecular implications of NAB2-STAT6 fusion variants in solitary fibrous tumour	33
Head-to-head evaluation on diagnostic accuracies of six SARS-CoV-2 serological assays	33
Sample pooling is a viable strategy for SARS-CoV-2 detection in low-prevalence settings	31
The concept of mesothelioma in situ, with consideration of its potential impact on cytology diagnosis	27
Evaluation of the BioFire Blood Culture Identification 2 panel and impact on patient management and antimicrobial stewardship	26
The impact of viral transport media on PCR assay results for the detection of nucleic acid from SARS-CoV-2	26
Staging of renal cell carcinoma: current progress and potential advances	26
PD-1/PD-L1, Treg-related proteins, and tumour-infiltrating lymphocytes are associated with the development of oral squamous cell carcinoma	25
Evaluating errors in the laboratory identification of von Willebrand disease using contemporary von Willebrand factor assays	25
Angiomyolipoma of the kidney: from simple hamartoma to complex tumour	24
A multicentre assessment of contemporary laboratory assays for heparin induced thrombocytopenia	23
Emergence of Japanese encephalitis in Australia: a diagnostic perspective	23
Urothelial carcinoma: variant histology, molecular subtyping, and immunophenotyping significant for treatment outcomes	21
INSM1 is a novel prognostic neuroendocrine marker for luminal B breast cancer	20
Molecular pathology of prostate cancer: a practical approach	19
HADHB, a fatty acid beta-oxidation enzyme, is a potential prognostic predictor in malignant lymphoma	19
Silver nanoparticles as a bioadjuvant of antibiotics against biofilm-mediated infections with methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa in chronic rhinosinusitis patients	19
New developments in non-Hodgkin lymphoid malignancies	16

Aberrant protein expression of Appl1, Sortilin and Syndecan-1 during the biological progression of prostate cancer	16
Comparison of PD-L1 immunohistochemical assays in advanced gastric adenocarcinomas using endoscopic biopsy and paired resected specimens	16
Tumour-like lesions of the urinary bladder	15
Effect of macrotroponin on the utility of cardiac troponin I as a prognostic biomarker for long term total and cardiovascular disease mortality	15
Laboratory testing for platelet factor 4 antibodies: differential utility for diagnosis/exclusion of heparin induced thrombocytopenia versus suspected vaccine induced thrombotic thrombocytopenia	15
Virus isolation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for diagnostic and research purposes	15
SARS-CoV-2 viral load dynamics and real-time RT-PCR cycle threshold interpretation in symptomatic non-hospitalised individuals in New Zealand: a multicentre cross sectional observational study	15
Laboratory diagnosis of severe acute respiratory syndrome coronavirus 2	15
Stage T1 bladder cancer: diagnostic criteria and pitfalls	14
Prognostic features of Annexin A2 expression in prostate cancer	14
CAR-T cell therapy: practical guide to routine laboratory monitoring	14
EBV positive fibrin/chronic inflammation associated diffuse large B-cell lymphoma: an incidental finding associated with a breast implant	14
Machine learning and augmented human intelligence use in histomorphology for haematolymphoid disorders	14
Minimal residual disease in multiple myeloma: defining the role of next generation sequencing and flow cytometry in routine diagnostic use	14
Use of emerging testing technologies and approaches for SARS-CoV-2: review of literature and global experience in an Australian context	13
Myeloid somatic mutation panel testing in myeloproliferative neoplasms	13
Neuropathological findings in fatal COVID-19 and their associated neurological clinical manifestations	13
Variability in D-dimer reporting revisited	13
Accuracy amidst ambiguity: false positive SARS-CoV-2 nucleic acid tests when COVID-19 prevalence is low	12
Contamination of SARS-CoV-2 RT-PCR probes at the oligonucleotide manufacturer	12
An update on genomic aberrations in Spitz naevi and tumours	12
Rapid detection of the widely circulating B.1.617.2 (Delta) SARS-CoV-2 variant	12
The role of HER2 as a therapeutic biomarker in gynaecological malignancy: potential for use beyond uterine serous carcinoma	12
Benign mimics of prostate cancer	12
Clinical evaluation of four commercial immunoassays for the detection of antibodies against established SARS-CoV-2 infection	12
Diagnostic utility of PRAME, p53 and 5-hmC immunostaining for distinguishing melanomas from naevi, neurofibromas, scars and other histological mimics	12
Role of cell-free DNA in haematological malignancies	12
Evaluation of MTAP and p16 immunohistochemical deficiency as surrogate marker for CDKN2A/B homozygous deletion in gliomas	12
Clonal haematopoiesis of emerging significance	11
Spindle cell/sclerosing rhabdomyosarcoma with a novel YAP1-MAML2 fusion in a 1-year-old: not all strongly TRK-expressing spindle cell sarcomas in infants are infantile fibrosarcomas!	11
Alectinib induces marked red cell spheroacanthocytosis in a near-ubiquitous fashion and is associated with reduced eosin-5-maleimide binding	11
CD68-positive tumour associated macrophages, PD-L1 expression, and EBV latent infection in a high HIV-prevalent South African cohort of Hodgkin lymphoma patients	11
Tumour mutational burden: an overview for pathologists	11
Using deep learning for quantification of cellularity and cell lineages in bone marrow biopsies and comparison to normal age-related variation	10
Electron microscopic observations in perfusion-fixed human non-alcoholic fatty liver disease biopsies	10
Implementation and evaluation of a novel real-time multiplex assay for SARS-CoV-2: in-field learnings from a clinical microbiology laboratory	10
Diagnostic error, uncertainty, and overdiagnosis in melanoma	10
Atypia in breast pathology: what pathologists need to know	10
Urothelial carcinoma in situ: diagnostic update	10
The impact of grading scheme on non-muscle invasive bladder cancer progression: potential utility of hybrid grading schemes	10
Expression of PD-L1, cancer stem cell and epithelial–mesenchymal transition phenotype in non-small cell lung cancer	10
An evaluation of existing manual blood film schistocyte quantitation guidelines and a new proposed method	10
Angiogenesis, programmed death ligand 1 (PD-L1) and immune microenvironment association in laryngeal carcinoma	10
Genomic characterisation of diffuse large B-cell lymphoma	10
PRAME immunostain expression in sebaceous lesions, cutaneous carcinomas and adnexal structures	10
LncRNA PVT1 promotes the malignant progression of acute myeloid leukaemia via sponging miR-29 family to increase WAVE1 expression	9
NKX3.1 expression in cervical ‘adenoid basal cell carcinoma’: another gynaecological lesion with prostatic differentiation?	9
A Mycobacterium species for Crohn's disease?	9
Prostatic stromal proliferations: a review	9
Clinical evaluation of SARS-CoV-2 point-of-care antibody tests	9

GLI activated epithelioid cell tumour: report of a case and proposed new terminology	9
Clinicopathological significance of multiple molecular features in undifferentiated and dedifferentiated endometrial carcinomas	9
Comparable survival outcome between acquired cystic disease associated renal cell carcinoma and clear cell carcinoma in patients with end-stage renal disease: a multi-institutional central pathology s	9
Programmed cell death 1 ligand 1 (PD-L1) expression is associated with poor prognosis of malignant pleural mesothelioma patients with good performance status	9
Longitudinal evaluation of laboratory-based serological assays for SARS-CoV-2 antibody detection	9
Percentage grade 4 tumour predicts outcome for prostate adenocarcinoma in needle biopsies from patients with advanced disease: 10-year data from the TROG 03.04 RADAR trial	9
SARS-CoV-2 antibodies in the Southern Region of New Zealand, 2020	8
The utility and limitations of B- and T-cell gene rearrangement studies in evaluating lymphoproliferative disorders	8
Prevalence of T-cell antigen losses in mycosis fungoides and CD30-positive cutaneous T-cell lymphoproliferations in a series of 153 patients	8
The neurotrophic tyrosine kinase receptor 1 (TrkA) is overexpressed in oesophageal squamous cell carcinoma	8
Melanoma with osseous or chondroid differentiation: a report of eight cases including SATB2 expression and mutation analysis	8
Detection of NTRK fusions in glioblastoma: fluorescent in situ hybridisation is more useful than pan-TRK immunohistochemistry as a screening tool prior to RNA sequencing	8
Should the solid variant of odontogenic keratocyst and keratoameloblastoma be classified as the same entity? A clinicopathological analysis of nine cases and a review of the literature	8
Metastatic melanoma and rare melanoma variants: a review	8
NTRK-rearranged spindle cell neoplasms: a clinicopathological and molecular study of 13 cases with peculiar characteristics at one of the largest institutions in China	8
Vancomycin variable Enterococcus (VVE), E. faecium, harbouring the vanA gene complex	8
Malignant transformation of fibrous dysplasia into osteosarcoma confirmed with TP53 somatic mutation and mutational analysis of GNAS gene	8
Progression of mesothelioma in situ to invasive disease 4 years and 10 months after initial diagnosis	8
Comparison of a commercial real-time PCR panel to routine laboratory methods for the diagnosis of meningitis-encephalitis	8
Quantitative Pneumocystis jirovecii real-time PCR to differentiate disease from colonisation	8
SARS-CoV-2 N-gene mutation leading to Xpert Xpress SARS-CoV-2 assay instability	8
Prognostic and predictive biomarkers in melanoma	7
Institutional characterisation of water clear cell parathyroid adenoma: a rare entity often unrecognised by TC-99m-sestamibi scintigraphy	7
Weak positive SARS-CoV-2 N2 gene results using the Xpress Xpert assay: the need for an alternate interpretative criteria in a low prevalence setting	7
Subtyping intestinal metaplasia in patients with chronic atrophic gastritis: an interobserver variability study	7
Clinical correlation of lymphovascular invasion and Silva pattern of invasion in early-stage endocervical adenocarcinoma: proposed binary Silva classification system	7
Erythrocyte interaction with neutrophil extracellular traps in coronary artery thrombosis following myocardial infarction	7
HPV-driven anal neoplasia: review and recent developments	7
A comparison of ThinPrep against four non-volatile transport media for HPV testing at or near the point of care	7
Histopathological typing in diffuse malignant epithelioid mesothelioma: implication for prognosis and molecular basis	7
Prevalence and clinical significance of portal inflammation, portal plasma cells, interface hepatitis and biliary injury in liver biopsies from patients with non-alcoholic steatohepatitis	7
SMARCB1/INI1-deficient primary lung carcinoma with hepatic metastasis	6
Assessment of analytical bias in ferritin assays and impact on functional reference limits	6
Cytological diagnosis of mesothelioma in situ versus invasive mesothelioma	6
Fibroblast activation protein as a potential theranostic target in brain metastases of diverse solid tumours	6
Is prostate infarction and acute urinary retention a possible complication of severe COVID-19 infection?	6
Design, implementation and clinical utility of next generation sequencing in myeloid malignancies: acute myeloid leukaemia and myelodysplastic syndrome	6
Sialadenoma papilliferum of the bronchus: focus on histological and genetic distinction from mixed squamous cell and glandular papilloma	6
The biology of pancreatic cancer morphology	6
Stimulator of interferon genes (STING) immunohistochemical expression in the spectrum of perivascular epithelioid cell (PEC) lesions of the kidney	6
Actinomycosis canaliculitis	6
Primary pancreatic spindle cell sarcoma with a TMEM106B::BRAF gene fusion treated with MEK inhibition	6
Immune cell infiltration, tumour budding, and the p53 expression pattern are important predictors in penile squamous cell carcinoma: a retrospective study of 152 cases	6
Clinical associations of SARS-CoV-2 viral load using the first WHO International Standard for SARS-CoV-2 RNA	6
Biology and genetics of acquired and congenital melanocytic naevi	6
Tumour infiltrating lymphocyte density differs by meningioma type and is associated with prognosis in atypical meningioma	6
Comparison of three commercially available ELISA assays for anti-infliximab antibodies	6
Inflammatory pseudotumour arising secondary to VEXAS syndrome	6
Gleason grade 5 prostate cancer: sub-patterns and prognosis	6
Blood culture quality assurance: what Australasian laboratories are measuring and opportunities for improvement	6
A NUT carcinoma lacking squamous differentiation and expressing TTF1	6
Impact of new myeloma agents on the transfusion laboratory	6
Diagnosis of rare subtypes of acute myeloid leukaemia and related neoplasms	6
Blue naevi and the blue tumour spectrum	5
Gynaecological or gastrointestinal origin? Recognising Müllerian neoplasms with gastrointestinal phenotype and determining the primary site in selected entities	5
Aberrant p16, p53 and Ki-67 immunohistochemistry staining patterns can distinguish solitary keratoacanthoma from cutaneous squamous cell carcinoma	5
Proficiency testing for bacterial whole genome sequencing in assuring the quality of microbiology diagnostics in clinical and public health laboratories	5
The path(ology) from reflux oesophagitis to Barrett oesophagus to oesophageal adenocarcinoma	5
Prospective cohort study on the use of low molecular weight heparin calibrated anti-Xa assay for measurement of direct oral Xa inhibitors in ex vivo patient samples	5
Cemento-osseous dysplasia is caused by RAS-MAPK activation	5
The diverse morphology and immunophenotype of ovarian endometrioid carcinomas	5
Subungual melanoma with blue naevus-like morphological features: a clinicopathological retrospective analysis of nine cases	5
Multi-site point of care assessment of Abbott ID NOW rapid molecular test for SARS-CoV-2 in a low-prevalence setting	5
Local genomic sequencing enhances COVID-19 surveillance in the Northern Territory of Australia	5
Analysis of recurrent molecular alterations in phyllodes tumour of breast: insights into prognosis and pathogenesis	5
Primary cutaneous methotrexate-associated B-cell lymphoproliferative disorders other than EBV-positive mucocutaneous ulcer: clinical, pathological, and immunophenotypic features	5
Melanocytic naevi, melanocytomas and emerging concepts	5
Controversies in appendiceal pathology: mucinous and goblet cell neoplasms	5
Highlights of infectious agents in tissue	5
An update on genetic aberrations in T-cell neoplasms	5
Appl1, Sortilin and Syndecan-1 immunohistochemistry on intraductal carcinoma of the prostate provides evidence of retrograde spread	5
Proficiency testing for SARS-CoV-2 whole genome sequencing	5
An overview of artificial intelligence/deep learning	5
Analysis of SARS-CoV-2 real-time PCR test CT values across a population may afford useful information to assist public health efforts and add refinement to epidemiological models	4
The clinicopathological spectrum of sclerosing epithelioid fibrosarcoma: report of an additional series with review of the literature	4
Refined criteria for p53 expression in ovarian mucinous tumours are highly concordant with TP53 mutation status, but p53 expression/TP53 status lack prognostic significance	4
Molecular testing in melanoma for the surgical pathologist	4
Mesenchymal tumours with melanocytic expression: a potential pitfall in the differential diagnosis of malignant melanoma	4
Independent validation of distinct clinicopathological features and prognosis among usual-type, mucinous-type and gastric-type endocervical adenocarcinoma categorised by new WHO classification (2020)	4
High expression of progesterone receptor may be an adverse prognostic factor in oestrogen receptor-negative/progesterone receptor-positive breast cancer: results of comprehensive re-evaluation of mult	4

Comparative analysis of three laboratory based serological assays for SARS-CoV-2 in an Australian cohort	4
Recurrent plexiform angiomyxoid myofibroblastic tumour (PAMT) of the stomach with aggressive behaviour	4
Elevated non-coding promoter mutations are associated with malignant transformation of melanocytic naevi to melanoma	4
Gastrointestinal polyposis with associated cutaneous manifestations	4
Performance evaluation of Roche and Abbott Panbio multiplex SARS-CoV-2 and influenza A/B rapid antigen tests	4
ROS1 rearrangements in lung adenocarcinomas are defined by diffuse strong immunohistochemical expression of ROS1	4
Spinal calcifying pseudoneoplasm of the neuraxis (CAPNON) and CAPNON-like lesions: CAPNON overlapping with calcified synovial cysts	4
IgG4-related pseudotumours: a series of 12 cases and a review of the literature	4
Oxford nanopore next generation sequencing in a front-line clinical microbiology laboratory without on-site bioinformaticians	4
Invasive poorly differentiated adenocarcinoma of the bladder following augmentation cystoplasty: a multi-institutional clinicopathological study	4
Expression and localisation of methylthioadenosine phosphorylase (MTAP) in oral squamous cell carcinoma and their significance in epithelial-to-mesenchymal transition	4
NKX3.1 immunohistochemistry is highly specific for the diagnosis of mesenchymal chondrosarcomas: experience in the Australian population	4
Whole genome sequencing of Salmonella enterica serovar Saintpaul for elucidating the mechanisms of resistance to third generation cephalosporins	4
Characterisation of the protein expression of the emerging immunotherapy targets VISTA, LAG-3 and PRAME in primary uveal melanoma: insights from a southern French patient cohort	4
Exosomes and microvesicles in kidney transplantation: the long road from trash to gold	4
Regression in cutaneous melanoma: histological assessment, immune mechanisms and clinical implications	4
Liver mesenchymal neoplasms: something old, something new	4
The Ring Study: an international comparison of PD-L1 diagnostic assays and their interpretation in non-small cell lung cancer, head and neck squamous cell cancer and urothelial cancer	4
Improved performance of confirmatory assays for detecting dense fine speckled (DFS) 70 antibodies	4
BRAF mutation testing for patients diagnosed with stage III or stage IV melanoma: practical guidance for the Australian setting	4
Assessing the performance of the Cepheid Xpert in identifying and differentiating methicillin-susceptible Staphylococcus aureus and methicillin-resistant Staphylococcus aureus from blood culture bottl	4
Immunophenotypic and genomic landscape of Richter transformation diffuse large B-cell lymphoma	4
Dedifferentiated melanoma with MDM2 gene amplification mimicking dedifferentiated liposarcoma	4
Analytical sensitivity and specificity of the Cepheid Xpert Xpress SARS-CoV-2/Flu/RSV assay	4
Cytotoxic CD8-positive T-lymphocyte infiltration in the lungs as a histological pattern of SARS-CoV-2 pneumonitis	4
Malignant gastrointestinal neuroectodermal tumour in soft tissue	4
Prognostic significance of morphological patterns of Gleason grade 5 prostatic adenocarcinoma diagnosed on needle biopsy	4
LOT and HOT … or not. The proliferation of clinically insignificant and poorly characterised types of renal neoplasia	4
Clinicopathological analysis of myeloid sarcoma with megakaryocytic differentiation	4
Immature platelet fraction as a predictor of platelet count recovery following allogeneic bone marrow transplantation	4
Morphologic and molecular analysis of Richter syndrome in chronic lymphocytic leukaemia patients treated with ibrutinib or venetoclax	4
Eosinophilic renal cell carcinoma with isolated MTOR mutation metastatic to the liver: a novel case	4
Imaging flow cytometry shows monosomy 17 in circulating plasma cells in myeloma	4
Panfungal PCR on formalin-fixed, paraffin-embedded tissue: to proceed or not proceed?	4
Re: INSM1 is a novel prognostic neuroendocrine marker for luminal B breast cancer	4
Agminated Spitz naevus with an activating HRAS Q61R mutation	4
Current updates in sarcoma biomarker discovery: emphasis on next-generation sequencing-based methods	4
Usual interstitial pneumonia: a review of the pathogenesis and discussion of elastin fibres, type II pneumocytes and proposed roles in the pathogenesis	4
In-house multiplex ligation-dependent probe amplification assay for citrin deficiency: analytical validation and novel exonic deletions in SLC25A13	3
TERT promoter methylation and protein expression as predictive biomarkers for recurrence risk in patients with serous borderline ovarian tumours	3
A novel prognostic nomogram for predicting survival in diffuse pleural mesothelioma	3
Gluten-free diet adherence and implications for the diagnosis of coeliac disease	3
HER2-low breast cancer and response to neoadjuvant chemotherapy: a population-based cohort study	3
Prognostic and predictive biomarkers in central nervous system tumours: the molecular state of play	3
Antifungal susceptibility of clinical mould isolates in New Zealand, 2001–2019	3
Tumour infiltrating lymphocytes in oropharyngeal carcinoma: prognostic value and evaluation of a standardised method	3
Histo-blood group antigens and rotavirus vaccine virus shedding in Australian infants	3
YJ5 as an immunohistochemical marker of osteogenic lineage	3
Meningioma sampling: how much is enough for the accurate grading of atypical meningiomas?	3
Contributions of genetics to the evolution of the diagnostic classification of renal cell neoplasia: a personal perspective	3
Prolonged PCR positivity in elderly patients infected with SARS-CoV-2	3
Predictive and prognostic biomarkers in female genital tract tumours: an update highlighting their clinical relevance and practical issues	3
Spatial disparities in the reported incidence and survival of myeloproliferative neoplasms in Australia	3
IgG4-related autoimmune pancreatitis-like mass-forming lesion on a background of immune checkpoint inhibitor immunotherapy	3
Demystifying oral epithelial dysplasia: a histological guide	3
Intravascular epithelioid haemangioma of deep soft tissue with novel SETD1B-FOSB gene rearrangement	3
Molecular typing of enteroviruses: comparing 5′UTR, VP1 and whole genome sequencing methods	3
Lack of standardisation in interpretation and reporting of autoantibody assays: a survey analysis of Australasian laboratories with focus on line immunoassays	3
Intracranial mesenchymal tumour with EWSR1 gene rearrangement: the first report of intracranial mesenchymal tumour with FET-CREB fusion from India	3
Biomarkers and biomarker validation: a pathologist's guide to getting it right	3
Precision diagnostics: integration of tissue pathology and genomics in cancer	3
Prolonged granulocyte transfusions sourced from buffy coats used to treat Aspergillus spp. infection in chronic granulomatous disease	3
Representativeness of initial skin biopsies showing pure desmoplastic melanoma: implications for management	3
Predicting survival in colorectal carcinoma after curative resection: a new prognostic nomogram	3
Interobserver agreement in the histopathological classification of desmoplastic melanomas	3
The choice of anti-LEDGF/DFS70 assay matters: a comparative study of six assays	3
Enterococcus cecorum infective endocarditis in a patient with chronic myeloid leukaemia and cirrhosis	3
Proficiency testing for SARS-CoV-2 in assuring the quality and overall performance in viral RNA detection in clinical and public health laboratories	3
Efficacy of training a deep learning model for mitotic count in breast carcinoma using opensource software	3
The future of laboratory testing in chronic lymphocytic leukaemia	3
Expression of SATB2 in primary cutaneous sarcomatoid neoplasms: a potential diagnostic pitfall	3
ASPSCR1-TFE3 fusion in a case of Xp11 translocation PEComa of the liver: are ASPSCR1-TFE3 fusion-bearing tumours Xp11 translocation PEComa or alveolar soft part sarcoma?	3
Prognostic and predictive biomarkers in non-small cell lung carcinoma	3
Pathology utilisation during COVID-19 outbreaks beyond viral testing: routine coagulation and D-dimer testing	3
Necrosis is an independent predictor of disease-free and overall survival in pancreatic well-differentiated neuroendocrine tumours (NETs): a proposal to include it in grading systems	3
Design and validation of an LC-MS/MS method for simultaneous quantification of asymmetric dimethylguanidino valeric acid, asymmetric dimethylarginine and symmetric dimethylarginine in human plasma	3
Predictive and prognostic biomarkers in urological tumours	3
NTRK fusions in solid tumours: what every pathologist needs to know	3
Ovarian mesonephric-like adenocarcinoma: morphological diversity and histogenetic considerations of an unusual tumour	3
Idiopathic granulomatous mastitis and cystic neutrophilic granulomatous mastitis: two sides of the same coin or distinct entities?	3
Laboratory diagnosis of HIV: a contemporary overview in the Australian context	3
Review of full blood count reference interval using a large cohort of first-time plasmapheresis blood donors	3
Increased diagnostic yield of routine multiplex PCR compared to clinician requested testing for detection of Trichomonas vaginalis	3
HMGCR autoantibody testing: two tiers required	3
Overexpression of interleukin-20 correlates with favourable prognosis in diffuse large B-cell lymphoma	3
Cutaneous clear cell sarcoma with an epidermal component mimicking melanoma	3
Glomeruloid haemangioma pattern in reactive angioendotheliomatosis leading to the diagnosis of POEMS syndrome	3
Missing parameters in malignant polyp histology reports: can appropriate decisions be made?	3
Bone marrow fibrosis impact on response to azacitidine in myelodysplastic syndromes	2
Unsupervised computational detection of measurable residual disease in chronic lymphocytic leukaemia	2
A case of COVID-19 mRNA vaccine-related erythema nodosum and interstitial granulomatous drug reaction	2
Verification of the BioFire FilmArray Pneumonia Plus Panel for pathogen screening of respiratory specimens	2
Low HES-1 and positive DLL4 expression predicts poor prognosis of colorectal cancers	2
Counting mitoses: SI(ze) matters	2
An unusual case of invasive lobular carcinoma with abundant extracellular mucin	2